Publication | Closed Access

Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X

HypertensionCardiovascular DiseaseMedicineVascular PharmacologyCoronary Microvascular FunctionEndothelial DysfunctionCardiovascular PharmacologyCardiologyVascular BiologyPharmacotherapyMicrovascular DysfunctionPharmacologyAsymmetric DimethylarginineAtherosclerosisSyndrome X